At a glance
ClinicalIndex Comparison RecordN/ACompleted· 76 enrolled
Drug / intervention
Dexamethasone +5 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Placebo Controlled, Double Blinded Study of Corticosteroid Treatment for the Reduction of Postoperative Pain Following Transoral Robotic Surgery
In Brief
A clinical study evaluating Dexamethasone, Placebo, and 3 other interventions for Dysphagia and 4 related conditions. Completed, enrolled 76 participants across 1 site.
Detailed Summary
This randomized pilot clinical trial studies dexamethasone in reducing oral pain and dry mouth after surgery in patients with oropharyngeal cancer. Dexamethasone may help lower pain and dry mouth caused by surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDysphagia, Pain, Stage I Oropharyngeal Squamous Cell Carcinoma, Stage II Oropharyngeal Squamous Cell Carcinoma, Stage III Oropharyngeal Squamous Cell Carcinoma
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2012
First PostedDec 2012
Primary CompletionJul 2016
Study CompletionMar 2017
TodayJul 2026
First PostedDec 13, 2012
Enrollment StartDec 1, 2012
Primary CompletionJul 1, 2016
Study CompletionMar 29, 2017
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 13.6 years ago
Interventions
Dexamethasonedrug
Given IV
Dexamethasonedrug
Given PO
Placeboother
Given PO
Quality-of-Life Assessmentprocedure
Ancillary studies
Questionnaire Administrationother
Ancillary studies
Transoral Robotic Surgeryprocedure
Undergo TORS